Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein
NCT00001561Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of FavId in multiple myeloma (MM), sponsored by National Cancer Institute. Started Nov 1996; status: completed.
02
Drugs
FavId
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00001561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001561.